Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- A(H7N9) 1
- Ace2 1
- Administration, Intranasal 1
- Adolescent 9
- Adult 9
- Aged 7
- Algorithms 1
- Ambulatory Care 2
- Angiotensin-Converting Enzyme 2 1
- Animals 5
- Antibodies, Monoclonal 1
- Antibodies, Viral 1
- Antigens, Viral 1
- Antiviral 1
- Antiviral Agents 7
- Article 4
- Avian influenza 1
- Binding Sites 1
- Birds 1
- Cap-dependent endonuclease inhibitor 1
- Cat Diseases 1
- Cell Lines 1
- Chick Embryo 1
- Chickens 1
- Child 8
- Child, Preschool 8
- Child Mortality 6
- Clinical Laboratory Information Systems 2
- Clinical Laboratory Services 2
- Coinfection 1
- Computational Biology 1
- Coronavirus Disease 1
- Coronavirus Infections 1
- Cost of Illness 1
- COVID-19 2
- Covid-19 1
- COVID-19/epidemiology 1
- Databases, Genetic 1
- Dibenzothiepins 1
- Disease Models, Animal 1
- Disease Notification 2
- Disease Outbreaks 6
- Disease Transmission, Infectious 1
- Dispatch 4
- Dogs 1
- Drug Resistance, Viral 12
- Female 3
- Full Report 11
- Genetic Variation 1
- Genome, Viral 2
- Genomic Instability 1
- Genomics 1
- Global Health 3
- Hemagglutinin Glycoproteins, Influenza Virus 1
- High-Throughput Nucleotide Sequencing 2
- Hospitalization 7
- Housing, Animal 1
- Humans 24
- Immunologic Factors 1
- Immunotherapeutic 1
- Infant 8
- Infant, Newborn 7
- Infant Mortality 3
- Influenza 2
- Influenza, Human 19
- Influenza A Virus 2
- Influenza A virus 1
- Influenza A Virus, H1N1 Subtype 12
- Influenza A Virus, H1N2 Subtype 4
- Influenza A Virus, H3N2 Subtype 12
- Influenza A Virus, H5N1 Subtype 1
- Influenza A Virus, H7N2 Subtype 3
- Influenza A Virus, H7N9 Subtype 2
- Influenza B Virus 11
- Influenza B virus 2
- Influenza In Birds 1
- Influenza in Birds 1
- Influenza Vaccines 8
- Laboratories 3
- Male 3
- Microbial Sensitivity Tests 3
- Middle Aged 8
- Neuraminidase 4
- Orthomyxoviridae Infections 3
- Oseltamivir 2
- Outpatients 6
- Phylogeny 2
- Pneumonia 7
- Population Surveillance 12
- Pregnancy 2
- Prevalence 3
- Rapid Communication 2
- SARS-CoV-2 2
- Seasons 12
- Sequence Analysis, DNA 2
- Swine 2
- Swine Diseases 2
- Viruses 2
- Young Adult 9
- Zoonoses 2
Personal Author
Corporate Author
- 2013–14 US Influenza Antiviral Working Group 1
- Bioinformatic Working Group 1
- Center for Surveillance, Epidemiology, and Laboratory Services (U.S.). Division of Laboratory Systems. 2
- Centers for Disease Control and Prevention (U.S.) 1
- Idaho. Department of Health and Welfare. Division of Public Health. 1
- National Center for Immunization and Respiratory Diseases (U.S.)Influenza Division. 3
- NS3 Working Group 1
- Southwest District Health (Caldwell, Idaho) 1
- Strain Surveillance and Emerging Variants 1
Place as Subject
- China 1
- Idaho 1
- India 1
- Louisiana 1
- New York City, NY 1
- Peru 1
- U.S. 1
- United States 13
Resource Type General
Resource Type Specific
- Webinar 2
Select all docs (Max 200)
1 -
20 of 32 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- A(H7N9) (1)
- Ace2 (1)
- Administration, Intranasal (1)
- Adolescent (9)
- Adult (9)
- Aged (7)
- Algorithms (1)
- Ambulatory Care (2)
- Angiotensin-Converting Enzyme 2 (1)
- Animals (5)
- Antibodies, Monoclonal (1)
- Antibodies, Viral (1)
- Antigens, Viral (1)
- Antiviral (1)
- Antiviral Agents (7)
- Article (4)
- Avian influenza (1)
- Binding Sites (1)
- Birds (1)
- Cap-dependent endonuclease inhibitor (1)
- Cat Diseases (1)
- Cell Lines (1)
- Chick Embryo (1)
- Chickens (1)
- Child (8)
- Child, Preschool (8)
- Child Mortality (6)
- Clinical Laboratory Information Systems (2)
- Clinical Laboratory Services (2)
- Coinfection (1)
- Computational Biology (1)
- Coronavirus Disease (1)
- Coronavirus Infections (1)
- Cost of Illness (1)
- COVID-19 (2)
- Covid-19 (1)
- COVID-19/epidemiology (1)
- Databases, Genetic (1)
- Dibenzothiepins (1)
- Disease Models, Animal (1)
- Disease Notification (2)
- Disease Outbreaks (6)
- Disease Transmission, Infectious (1)
- Dispatch (4)
- Dogs (1)
- Drug Resistance, Viral (12)
- Female (3)
- Full Report (11)
- Genetic Variation (1)
- Genome, Viral (2)
- Genomic Instability (1)
- Genomics (1)
- Global Health (3)
- Hemagglutinin Glycoproteins, Influenza Virus (1)
- High-Throughput Nucleotide Sequencing (2)
- Hospitalization (7)
- Housing, Animal (1)
- Humans (24)
- Immunologic Factors (1)
- Immunotherapeutic (1)
- Infant (8)
- Infant, Newborn (7)
- Infant Mortality (3)
- Influenza (2)
- Influenza, Human (19)
- Influenza A Virus (2)
- Influenza A virus (1)
- Influenza A Virus, H1N1 Subtype (12)
- Influenza A Virus, H1N2 Subtype (4)
- Influenza A Virus, H3N2 Subtype (12)
- Influenza A Virus, H5N1 Subtype (1)
- Influenza A Virus, H7N2 Subtype (3)
- Influenza A Virus, H7N9 Subtype (2)
- Influenza B Virus (11)
- Influenza B virus (2)
- Influenza In Birds (1)
- Influenza in Birds (1)
- Influenza Vaccines (8)
- Laboratories (3)
- Male (3)
- Microbial Sensitivity Tests (3)
- Middle Aged (8)
- Neuraminidase (4)
- Orthomyxoviridae Infections (3)
- Oseltamivir (2)
- Outpatients (6)
- Phylogeny (2)
- Pneumonia (7)
- Population Surveillance (12)
- Pregnancy (2)
- Prevalence (3)
- Rapid Communication (2)
- SARS-CoV-2 (2)
- Seasons (12)
- Sequence Analysis, DNA (2)
- Swine (2)
- Swine Diseases (2)
- Viruses (2)
- Young Adult (9)
- Zoonoses (2)
- 2013–14 US Influenza Antiviral Working Group (1)
- Bioinformatic Working Group (1)
- Center for Surveillance, Epidemiology, and Laboratory Services (U.S.). Division of Laboratory Systems. (2)
- Centers for Disease Control and Prevention (U.S.) (1)
- Idaho. Department of Health and Welfare. Division of Public Health. (1)
- National Center for Immunization and Respiratory Diseases (U.S.)Influenza Division. (3)
- NS3 Working Group (1)
- Southwest District Health (Caldwell, Idaho) (1)
- Strain Surveillance and Emerging Variants (1)
- :Shcherbik, Svetlana ;Sergent, Sheila B.September 18 2013 | J Virol Methods. 195:18-25:Development and improvement of quality control tests for live attenuated vaccines are a high priority because of safety concerns. Live attenuated infl...
- :Jorquera, Patricia A. ;Mishin, Vasiliy P.February 25 2019 | Sci Rep. 9:Influenza A(H3N2) viruses evade human immunity primarily by acquiring antigenic changes in the haemagglutinin (HA). HA receptor-binding features of co...
- :Gubareva, Larisa V ;Mishin, Vasiliy PJan 2019 | Euro Surveill. 2019; 24(3):The anti-influenza therapeutic baloxavir targets cap-dependent endonuclease activity of polymerase acidic (PA) protein. We monitored baloxavir suscept...
- :Gubareva, Larisa V ;Fallows, EricMay 04 2017 | Euro Surveill. 2017; 22(18):A new rapid assay for detecting oseltamivir resistance in influenza virus, iART, was used to test 149 clinical specimens. Results were obtained for 13...
- :Gargis, Amy S ;Kalman, LisaJul 2015 | Nat Biotechnol. 33(7):689-693
- :Wang, Li ;Fan, Xiaoyu2021 | Emerg Infect Dis. 27(5):1380-1392:Co-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other viruses has been reported. We evaluated cell lines commonly u...
- :Mishin, Vasiliy P. ;Patel, Mira C.October 17 2019 | Emerg Infect Dis. 25(10):1969-1972:Baloxavir showed broad-spectrum in vitro replication inhibition of 4 types of influenza viruses (90% effective concentration range 1.2-98.3 nmol/L); s...
- :Wilson, Jason R. ;Belser, Jessica A.11 2017 | Virology. 511:214-221:The emergence of A(H7N9) virus strains with resistance to neuraminidase (NA) inhibitors highlights a critical need to discover new countermeasures for...
- :Marcenac, Perrine ;McCarron, Margaret12 2022 | Emerg Infect Dis. 2022; 28(Suppl 1):S26-S33:A network of global respiratory disease surveillance systems and partnerships has been built over decades as a direct response to the persistent threa...
- :Chaitram, Jasmine ;Thornburg, NatalieNovember 21, 2022 | Laboratory Outreach Communication System (LOCS) call ; January 23, 2023:11_21_2022_slides_508.pdf
- :Chaitram, Jasmine ;Thornburg, NatalieFebruary 27, 2023 | Laboratory Outreach Communication System (LOCS) call ; January 23, 2023:02_27_2023_slides_508.pdf
- :Okomo-Adhiambo, Margaret ;Fry, Alicia M.Jan 2015 | Emerg Infect Dis. 21(1):136-141.:We report characteristics of oseltamivir-resistant influenza A(H1N1)pdm09 viruses and patients infected with these viruses in the United States. Durin...
- :Sleeman, Katrina ;Guo, Zhu2013 | Emerg Infect Dis. 19(9):1521-1524.:Neuraminidase inhibitors are the only licensed antiviral medications available to treat avian influenza A(H7N9) virus infections in humans. According ...
- :Marinova-Petkova, Atanaska ;Laplante, JenDec 2017 | Emerg Infect Dis. 23(12):2046-2049.:An outbreak of influenza A(H7N2) virus in cats in a shelter in New York, NY, USA, resulted in zoonotic transmission. Virus isolated from the infected ...
- :Shepard, Samuel S. ;Meno, SarahSep 05 2016 | BMC Genomics. 17(1).:BackgroundDeep sequencing makes it possible to observe low-frequency viral variants and sub-populations with greater accuracy and sensitivity than eve...
- :Tinoco, Yeny O. ;Montgomery, Joel M.Jan 2016 | Influenza Other Respir Viruses. 10(1):47-56.:ObjectivesWe aimed to determine the frequency of pH1N1 transmission between humans and swine on backyard farms in Tumbes, Peru.DesignTwo‐year serial...
- :Blanton, Lenee ;Alabi, NoreenJun 30 2017 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):During the 2016-17 influenza season (October 2, 2016-May 20, 2017) in the United States, influenza activity* was moderate. Activity remained low throu...
- :Blanton, Lenee ;Dugan, Vivien G.February 15 2019 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):CDC collects, compiles, and analyzes data on influenza activity and Viruses in the United States During September 30, 2018-February 2, 2019,* influenz...
- :Budd, Alicia P. ;Abd Elal, Anwar IsaDec 14 2018 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Influenza activity in the United States was low during October 2018, and, although it increased slowly during November, activity remains low across mo...
- :Blanton, Lenee ;Mustaquim, DesireeFeb 17 2017 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):This report summarizes U.S. influenza activity* during October 2, 2016-February 4, 2017,| and updates the previous summary (1). Influenza activity in ...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.